Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization

Area of Science:

• Biotechnology
• Genetics
• Molecular Biology

Background:

• Antisense oligonucleotides (ASOs) are increasingly approved for treating human disorders.
• ASOs are modified DNA/RNA oligos designed to interact with RNA targets.
• Their stability and duplex-forming properties enable genetic expression modulation.

Purpose of the Study:

• To review ASO strategies for congenital diseases and age-related syndromes.
• To discuss mechanisms of non-targeted ASO internalization into cells.
• To highlight the growing clinical relevance of ASO therapeutics.

Main Methods:

• Literature review of ASO applications in genetic and age-related diseases.
• Analysis of ASO modifications for enhanced stability and efficacy.
• Exploration of cellular uptake pathways for ASOs.

Main Results:

• ASOs demonstrate significant potential in treating a range of genetic disorders.
• Various ASO strategies are effective against congenital and aging-related conditions.
• Understanding non-targeted internalization mechanisms is crucial for optimizing ASO delivery.

Conclusions:

• ASO therapeutics are a rapidly advancing field with broad clinical applications.
• The review provides insights into current and future ASO treatment strategies.
• Further research into ASO internalization will enhance their therapeutic efficacy.